PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.520.06 (-1.08%)
5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.31%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-15.76%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-30.00%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-471.05%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-210.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-200.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-200.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
3.33%
Slight or no buybacks while UPM.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
3.33%
Slight or no buyback while UPM.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Dividend reduction while UPM.HE stands at 0.37%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
63.80%
Positive OCF growth while UPM.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
34.33%
Positive FCF growth while UPM.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-11.13%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-7.32%
Negative 5Y CAGR while UPM.HE stands at 16.85%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-30.64%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-118.25%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-113.31%
Negative 5Y OCF/share CAGR while UPM.HE is at 16.03%. Joel Greenblatt would question the firm’s operational model or cost structure.
-466.83%
Negative 3Y OCF/share CAGR while UPM.HE stands at 120.59%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-140.00%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-140.00%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-120.00%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
75.42%
10Y equity/share CAGR above 1.5x UPM.HE's 32.56%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
31.52%
5Y equity/share CAGR above 1.5x UPM.HE's 8.33%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-1.63%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-100.00%
Cut dividends over 10 years while UPM.HE stands at 7.67%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-4.18%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-7.63%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.76%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-4.68%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-71.95%
We’re deleveraging while UPM.HE stands at 5.34%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.